L868-0969 Screening compound: N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide

L868-0969 Screening compound: N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide
L868-0969 Screening compound: N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L868-0969
N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L868-0969

Molecular Formula

C21H28N4O3 (C21 H28 N4 O3)

Compound Name

N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide

IUPAC name

N-[(4-methoxyphenyl)methyl]-2-{[6-methyl-2-(3-methylpiperidin-1-yl)pyrimidin-4-yl]oxy}acetamide

SMILES

CC(CCC1)CN1c1nc(C)cc(OCC(NCc(cc2)ccc2OC)=O)n1

InChI

InChI=1S/C21H28N4O3/c1-15-5-4-10-25(13-15)21-23-16(2)11-20(24-21)28-14-19(26)22-12-17-6-8-18(27-3)9-7-17/h6-9,11,15H,4-5,10,12-14H2,1-3H3,(H,22,26)/t15-/m0/s1

InChI Key

BMINPBIZVVGKTR-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD16640209

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.545

Distribution Coefficient, logD

3.545

Water Solubility, LogSw

-3.61

Polar Surface Area

60.072

Acid Dissociation Constant (pKa)

14.24

Base Dissociation Constant (pKb)

9.19

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.60

L868-0969 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L868-0969 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L868-0969?
Check Price and Availability of L868-0969, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L868-0969 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L868-0969
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L868-0969
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L868-0969 available by request